The Omicron Covid variant may have led to more restrictions but the economic recovery remains resilient nevertheless. Which means stocks don't appear vulnerable to a correction. 01. Asset Allocation: Omicron unlikely to derail recovery ...

By Peter Garnry, Head of Equity Strategy, Saxo Bank Equities have had a fantastic year delivering 21% return following already extraordinary gains in 2020. It seems almost impossible given the galloping inflation not seen since the early 1980...

We want to help grow Neuberger Berman's name around equity investing, Senior portfolio manager Hendrik-Jan Boer, who joined the group with his team in November 2020, wants to realise this ambition. In an interview, he explained the strategy and ...

Policymakers’ pandemic response the previous year had led to new high-water marks in the US for money supply growth, which rose by 24 per cent in 2020, the biggest increase since records began before the Great Depression. The US personal savings r...

For the first time in a while, we do not have a strong conviction view on what the ECB will deliver and what the market implications could be. It is clear that the ECB will end the PEPP in March, and will maintain the APP. On average over the past...

WisdomTree, an exchange-traded fund (“ETF”) and exchange-traded product (“ETP”) sponsor, today announced the launch of the WisdomTree BioRevolution UCITS ETF (WDNA). Listed today on the London Stock Exchange and Börse Xetra, WDNA seeks to track ...